Nearly 90,000 containers of children’s ibuprofen have been recalled in the United States after the detection of an unidentified substance and black particles within them, as reported by Fox Business, citing information from the Food and Drug Administration (FDA).
According to media outlets, the recall for the 100-milligram containers of the medication was initiated by the Indian firm Strides Pharma Science. The recall order was issued in March, following reports concerning the presence of black particulates and a gel-like substance inside the vials.
The source of this anomalous material has not been specified.
Previously, lawyer Alla Georgieva explained that pharmaceutical products are eligible for return to the pharmacy if a defect is found or if the labeling lacks information in the Russian language.
She further noted that reimbursement for medications cannot be sought merely because the purchaser has changed their mind. This stems from their inclusion in the “List of non-food items of proper quality not subject to exchange,” as established by Russian Government Decree No. 2463.
Nevertheless, in accordance with Article 18 of the “Law on Protection of Consumer Rights,” any product found to have a defect is returnable, including those purchased at a pharmacy.
About the Author
